Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sanofi expects $120 million hit as dengue vaccine hits major snag

Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can worsen the disease in people who have not previously been exposed to the infection.

Read More »

Takeda moves ahead in Zika race with launch of vaccine trial

Japan’s Takeda Pharmaceutical moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.

Read More »

Texas calls in U.S. Air Force to counter post-storm surge in mosquitoes

Texas launched aerial attacks on mosquitoes swarming coastal regions of the state and threatening to spread disease and hinder disaster recovery in the aftermath of Hurricane Harvey.

Read More »

Zika affects 5 percent of babies with confirmed infections: CDC

The first report on how the Zika virus affected U.S. territories showed that 5 percent of women with confirmed infections had babies with birth defects, U.S. health officials said.

Read More »

Austrian biotech Themis launches Zika vaccine clinical trial

Austrian biotech company Themis Bioscience said it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease.

Read More »

Bernie Sanders: Trump Must Stop Sanofi’s Exclusive Zika Deal

U.S. Sen. Bernie Sanders is calling on President Donald Trump to carefully manage a deal between the U.S. Army and France-based pharma firm Sanofi to develop a Zika virus vaccine.

Read More »

Zika striking women at higher rates than men

Adult women in Puerto Rico were significantly more likely to develop Zika than men, researchers said, raising new questions about the potential role of sexual transmission of the virus from males to females.

Read More »

Brazil, Colombia scale up fight versus Zika, dengue

Health authorities in Colombia and Brazil will launch large-scale mosquito-control campaigns using a using naturally occurring bacteria known as Wolbachia.

Read More »

Google’s Verily to Tackle Zika

Verily, Google’s life sciences division, aims to eliminate the threat of the mosquito-borne Zika virus by figuring out how to prevent the pesky pests from reproducing.

Read More »

Study finds Zika infects neural cells related to skull formation

The Zika virus can infect and alter cells in the human nervous system that are crucial for formation of bones and cartilage in the skull, a study found.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom